IP Library Granted Patent US 12,376,762
Granted Patent B2
US 12,376,762 · App. 17/786,484 · Granted Aug 5, 2025

Cardiac tissue characterization using catheterized light scattering spectroscopy

Inventors: Nathan J. Knighton (Syracuse, UT); Robert W. Hitchcock (Salt Lake City, UT); Frank B. Sachse (Salt Lake City, UT)
Assignee: University of Utah Research Foundation
A61B5/061A61B1/0008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,376,762
App. No.
17/786,484
Filed
Jun 16, 2022
Granted
Aug 5, 2025
Kind
B2
Art Unit
3796
USPC
600/300
Abstract

Disclosed are devices, systems, and methods for characterizing tissue using light scattering spectroscopy. A tissue characterization probe includes an elongate member having a proximal end and a plurality of distal probe tips at a distal end. A plurality of illumination fibers extend through the elongate member to the distal probe tips such that each distal probe tip includes at least one illumination fiber. A plurality of detection fibers also extend through the elongate member such that each probe tip includes at least one detection fiber. The disclosed devices and systems beneficially enable characterization of tissues within depths greater than 100 μm. The disclosed devices and systems also enable effective characterization of anisotropic tissues, such as cardiac myocardium.

Claims (107)

1. A tissue characterization probe, comprising:

an elongate member having a proximal end and a distal end;

a plurality of distal probe tips disposed at or near the distal end of the elongate member to form a multi-arm arrangement;

a plurality of illumination fibers extending at least partially through the elongate member, each illumination fiber extending to a respective probe tip of the multi-arm arrangement such that each probe tip includes at least one illumination fiber; and

a plurality of detection fibers extending at least partially through the elongate member, each detection fiber extending to a respective probe tip of the multi-arm arrangement such that each probe tip includes at least one detection fiber,

wherein the probe is configured to be introduced through a lumen or working channel of a catheter, guidable catheter, steerable sheath or working channel of an endoscope, and is extendable beyond the tip of catheter, sheath or working channel.

2. A tissue characterization system, comprising:

(i) a tissue characterization probe that comprises:

an elongate member having a proximal end and a distal end;

a plurality of distal probe tips disposed at or near the distal end of the elongate member to form a multi-arm arrangement;

a plurality of illumination fibers extending at least partially through the elongate member, each illumination fiber extending to a respective probe tip of the multi-arm arrangement such that each probe tip includes at least one illumination fiber; and

a plurality of detection fibers extending at least partially through the elongate member, each detection fiber extending to a respective probe tip of the multi-arm arrangement such that each probe tip includes at least one detection fiber;

(ii) a light source operatively coupled to the illumination fiber; and

(iii) one or more spectrometers operatively coupled to the detection fibers.

3. The tissue characterization system of claim 2 , wherein the system is configured to characterize tissue within a depth greater than about 100 μm and up to about 30 mm.

4. The tissue characterization system of claim 2 , wherein the system is configured to characterize structurally anisotropic tissues.

5. A tissue characterization probe, comprising:

an elongate member having a proximal end and a distal end;

a distal probe tip disposed at the distal end of the elongate member;

an illumination fiber extending at least partially through the elongate member to the probe tip and configured to direct light toward target tissue, the illumination fiber defining an illumination axis; and

a plurality of detection fibers extending at least partially through the elongate member to the probe tip and configured to receive light scattered from the targeted tissue,

wherein a first set of detection fibers is substantially disposed along a first detection line, the first detection line being orthogonal to the illumination axis,

wherein a second set of detection fibers is substantially disposed along a second detection line, the second detection line being orthogonal to the illumination axis and being transverse to the first detection line,

wherein the probe is configured to be introduced through a lumen or working channel of a catheter, guidable catheter, steerable sheath or working channel of an endoscope, and is extendable beyond the tip of catheter, sheath or working channel.

6. The tissue characterization probe of claim 5 , wherein each detection fiber is radially offset from its respective detection line by no more than about 30 degrees.

7. The tissue characterization probe of claim 5 , wherein the first detection line and second detection line cross each other at the illumination axis to form a transverse angle of about 30° to about 150°.

8. The tissue characterization probe of claim 5 , wherein the second detection line is orthogonal to the first detection line.

9. The tissue characterization probe of claim 5 , wherein the first set of detection fibers includes at least two detection fibers.

10. The tissue characterization probe of claim 5 , wherein the second set of detection fibers includes at least two detection fibers.

11. The tissue characterization probe of claim 5 , wherein the first set of detection fibers, the second set of detection fibers, or both are substantially adjacent the illumination fiber.

12. The tissue characterization probe of claim 5 , wherein the detection fibers are spaced apart from the illumination fiber.

13. The tissue characterization probe of claim 12 , wherein the detection fibers are spaced apart from each other.

14. The tissue characterization probe of claim 5 , further comprising a support wire extending at least partially through the elongate member to the probe tip and configured to increase bending stiffness of the probe tip.

15. The tissue characterization probe of claim 5 , further comprising a support wire extending at least partially through the elongate member to the probe tip and configured to form a bend in the distal end of the probe tip.

16. The tissue characterization probe of claim 14 , wherein the support wire has a quadrilateral cross-sectional shape.

17. The tissue characterization probe of claim 16 , wherein the support wire has a rectangular cross-sectional shape.

18. The tissue characterization probe of claim 1 , wherein the probe further comprises one or more of an imaging assembly configured to provide microstructure imaging of targeted tissue, a localization assembly configured to provide location information of the distal tip within a three-dimensional anatomical working space, and/or a treatment assembly having one or more treatment components disposed at the distal tip for treating targeted tissue.

19. The tissue characterization probe of claim 18 , wherein the localization assembly comprises one or more electrodes, magnetic, optical, or other localization components to provide means for localization of the distal tip.

20. A tissue characterization system, comprising:

(i) a tissue characterization probe comprising:

an elongate member having a proximal end and a distal end;

a distal probe tip disposed at the distal end of the elongate member;

an illumination fiber extending at least partially through the elongate member to the probe tip and configured to, the illumination fiber defining an illumination axis; and

a plurality of detection fibers extending at least partially through the elongate member to the probe tip and configured to receive light scattered from the targeted tissue,

wherein a first set of detection fibers is substantially disposed along a first detection line, the first detection line being orthogonal to the illumination axis, and

wherein a second set of detection fibers is substantially disposed along a second detection line, the second detection line being orthogonal to the illumination axis and being transverse to the first detection line,

(ii) a light source operatively coupled to the illumination fiber; and

(iii) one or more spectrometers operatively coupled to the detection fibers.

21. The tissue characterization system of claim 20 , wherein the probe is configured to characterize tissue within a depth greater than about 100 μm and up to about 30 mm.

22. A method of characterizing tissue, comprising:

providing a tissue characterization system;

directing the distal probe tip to a targeted anatomical location;

at the targeted anatomical location, operating the tissue characterization probe to obtain spectra within depths greater than about 100 μm and up to about 30 mm; and

resolving the spectra in order to characterize the targeted tissue,

wherein the targeted tissue is cardiac tissue.

23. The method of claim 22 , wherein the targeted anatomical location is a blood-filled, beating heart.

24. The method of claim 22 , wherein characterizing the targeted tissue comprises detecting, measuring, or monitoring one or more of fibrosis, allograft acceptance or rejection, myocarditis, amyloidosis, hypertrophy, or nuclear density.

25. The method of claim 22 , wherein characterizing the targeted tissue comprises determining a volume fraction of constituents of the targeted tissue and/or spatial distribution of constituents of the targeted tissue within the heart.

26. The method of claim 22 , further comprising:

characterizing tissue at multiple target locations and obtaining one or more data points of the characterized tissue;

at each location of data acquisition, determine the location of the probe tip within the three-dimensional anatomical working space;

associating each data point with its corresponding determined location within the anatomical working space; and

based on the data points and their corresponding locations, generating a three-dimensional map of tissue microstructure.

27. The method of claim 26 , wherein the three-dimensional map is a fibrosis map.

28. The method of claim 26 , wherein the step of characterizing tissue at multiple target locations includes simultaneous characterization of tissues at the multiple target locations.

29. The method of claim 22 , wherein the step of resolving spectra in order to characterize the targeted tissue comprises utilizing an unsupervised machine learning technique.

30. The method of claim 29 , wherein the unsupervised machine learning technique includes cluster analysis.

31. The method of claim 30 , wherein the cluster analysis includes dimensionality reduction of spectra via principal component analysis (PCA).

32. The method of claim 31 , wherein the cluster analysis includes measuring similarity from at least the first and second principal components of the spectra.

33. The method of claim 32 , wherein similarity from at least the first and second principal components of the spectra is based on Euclidean distance.

34. The method of claim 22 , wherein the step of resolving spectra in order to characterize the targeted tissue comprises utilizing a supervised machine learning technique.

35. The method of claim 34 , wherein the supervised machine learning technique includes a convolutional neural network (CNN).

36. The method of claim 35 , wherein the CNN is trained and tested using data from a set of prior measurements of scattering in tissues.

37. The method of claim 35 , wherein a batch size for training of the CNN varies from 50 to 300.

38. The method of claim 35 , wherein a learning rate of the CNN varies from 0.0001 to 0.015.

39. The method of claim 35 , wherein a convolution filter kernel size of the CNN varies from 5 to 40.

40. The method of claim 35 , wherein the CNN is trained from spectra within specific wavelength ranges and/or is trained with reduced sampling.

41. A tissue characterization probe, comprising:

an elongate member having a proximal end and a distal end;

a distal probe tip disposed at the distal end of the elongate member;

an illumination fiber extending at least partially through the elongate member to the probe tip and configured to direct light toward target tissue, the illumination fiber defining an illumination axis; and

a plurality of detection fibers extending at least partially through the elongate member to the probe tip and configured to receive light scattered from the targeted tissue,

wherein a first set of detection fibers is substantially disposed along a first detection line, the first detection line being orthogonal to the illumination axis,

wherein a second set of detection fibers is substantially disposed along a second detection line, the second detection line being orthogonal to the illumination axis and being transverse to the first detection line, and

wherein each detection fiber is radially offset from its respective detection line by no more than about 30 degrees.

42. A tissue characterization probe, comprising:

an elongate member having a proximal end and a distal end;

a distal probe tip disposed at the distal end of the elongate member;

an illumination fiber extending at least partially through the elongate member to the probe tip and configured to direct light toward target tissue, the illumination fiber defining an illumination axis; and

a plurality of detection fibers extending at least partially through the elongate member to the probe tip and configured to receive light scattered from the targeted tissue,

wherein a first set of detection fibers is substantially disposed along a first detection line, the first detection line being orthogonal to the illumination axis,

wherein a second set of detection fibers is substantially disposed along a second detection line, the second detection line being orthogonal to the illumination axis and being transverse to the first detection line, and

wherein the first detection line and second detection line cross each other at the illumination axis to form a transverse angle of about 30° to about 150°.

43. A tissue characterization probe, comprising:

an elongate member having a proximal end and a distal end;

a distal probe tip disposed at the distal end of the elongate member;

an illumination fiber extending at least partially through the elongate member to the probe tip and configured to direct light toward target tissue, the illumination fiber defining an illumination axis;

a plurality of detection fibers extending at least partially through the elongate member to the probe tip and configured to receive light scattered from the targeted tissue; and

a support wire extending at least partially through the elongate member to the probe tip and configured to (i) increase bending stiffness of the probe tip, (ii) form a bend in the distal end of the probe tip, or both,

wherein a first set of detection fibers is substantially disposed along a first detection line, the first detection line being orthogonal to the illumination axis, and

wherein a second set of detection fibers is substantially disposed along a second detection line, the second detection line being orthogonal to the illumination axis and being transverse to the first detection line.

44. A method of characterizing tissue, comprising:

providing a tissue characterization system;

directing the distal probe tip to a targeted anatomical location;

at the targeted anatomical location, operating the tissue characterization probe to obtain spectra within depths greater than about 100 μm and up to about 30 mm; and

resolving the spectra in order to characterize the targeted tissue,

wherein the step of resolving spectra in order to characterize the targeted tissue comprises utilizing a supervised or an unsupervised machine learning technique.

Assignments (5)
CONFIRMATORY LICENSE Recorded Jan 22, 2024
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066360/0668 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2022
From: KNIGHTON, NATHAN J.; HITCHCOCK, ROBERT W.; SACHSE, FRANK B.
To: UNIVERSITY OF UTAH
Reel/Frame 061182/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2022
From: UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 061182/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2022
From: KNIGHTON, NATHAN J.; HITCHCOCK, ROBERT W.; SACHSE, FRANK B.
To: THE UNIVERSITY OF UTAH
Reel/Frame 060232/0557 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2022
From: THE UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 060232/0564 →
Continuity (2)
Provisional Application 62949290 · Dec 17, 2019
Related Publication 20230033444A1 · Feb 2, 2023
References Cited (115)
US 5429131A · Scheinman et al. · 1995 [cited by applicant]
US 5687737A · Branham et al. · 1997 [cited by applicant]
US 6004269A · Crowley et al. · 1999 [cited by applicant]
US 6228082B1 · Baker et al. · 2001 [cited by applicant]
US 7001383B2 · Keidar · 2006 [cited by applicant]
US 7499153B2 · Puppels et al. · 2009 [cited by applicant]
US 8029766B2 · Elmaleh et al. · 2011 [cited by applicant]
US 8059274B2 · Splinter · 2011 [cited by applicant]
US 8106905B2 · Markowitz et al. · 2012 [cited by applicant]
US 8316861B2 · Brewer et al. · 2012 [cited by applicant]
US 8432542B2 · Marple et al. · 2013 [cited by applicant]
US 8496579B2 · Koenig et al. · 2013 [cited by applicant]
US 8876815B2 · Coe et al. · 2014 [cited by applicant]
US 9763642B2 · Harks et al. · 2017 [cited by applicant]
US 10143398B2 · Altmann et al. · 2018 [cited by applicant]
US 10231706B2 · Chen et al. · 2019 [cited by applicant]
US 11154186B2 · Sachse et al. · 2021 [cited by applicant]
US 20040054366A1 · Davison et al. · 2004 [cited by applicant]
US 20040092806A1 · Sagon et al. · 2004 [cited by applicant]
US 20040092846A1 · Watrous · 2004 [cited by applicant]
US 20040153057A1 · Davison · 2004 [cited by applicant]
US 20040254474A1 · Seibel et al. · 2004 [cited by applicant]
US 20050033135A1 · Govari · 2005 [cited by applicant]
US 20050148836A1 · Kleen et al. · 2005 [cited by applicant]
US 20050242298A1 · Genet et al. · 2005 [cited by applicant]
US 20050288665A1 · Woloszko · 2005 [cited by applicant]
US 20060041199A1 · Elmaleh et al. · 2006 [cited by applicant]
US 20060229515A1 · Sharareh et al. · 2006 [cited by applicant]
US 20060253031A1 · Altmann et al. · 2006 [cited by applicant]
US 20070038123A1 · Fulghum · 2007 [cited by applicant]
US 20070179397A1 · Hashimshony et al. · 2007 [cited by applicant]
US 20070299352A1 · Harlev et al. · 2007 [cited by applicant]
US 20070299353A1 · Harlev et al. · 2007 [cited by applicant]
US 20080183036A1 · Saadat et al. · 2008 [cited by applicant]
US 20080262359A1 · Tearney et al. · 2008 [cited by applicant]
US 20080306391A1 · Hular · 2008 [cited by examiner]
US 20090076375A1 · Maschke · 2009 [cited by applicant]
US 20090076498A1 · Saadat et al. · 2009 [cited by applicant]
US 20090147257A1 · Splinter · 2009 [cited by applicant]
US 20090231578A1 · Ling · 2009 [cited by examiner]
US 20090299195A1 · Muller · 2009 [cited by examiner]
US 20090326320A1 · Sinofsky et al. · 2009 [cited by applicant]
US 20100092064A1 · Li · 2010 [cited by applicant]
US 20110028967A1 · Rollins et al. · 2011 [cited by applicant]
US 20110082451A1 · Melsky · 2011 [cited by applicant]
US 20110118590A1 · Zhang · 2011 [cited by applicant]
US 20110301438A1 · Sachse et al. · 2011 [cited by applicant]
US 20120053452A1 · Tal · 2012 [cited by applicant]
US 20120075619A1 · Nieman et al. · 2012 [cited by applicant]
US 20120108957A1 · Desai · 2012 [cited by applicant]
US 20120172724A1 · Hill et al. · 2012 [cited by applicant]
US 20120281218A1 · Schnitzer et al. · 2012 [cited by applicant]
US 20120302892A1 · Lue et al. · 2012 [cited by applicant]
US 20130102862A1 · Mercader et al. · 2013 [cited by applicant]
US 20130204134A1 · Harks et al. · 2013 [cited by applicant]
US 20130218019A1 · Abraham · 2013 [cited by applicant]
US 20130315455A1 · Wakai · 2013 [cited by applicant]
US 20140018792A1 · Gang et al. · 2014 [cited by applicant]
US 20140031802A1 · Melsky et al. · 2014 [cited by applicant]
US 20140058246A1 · Boveja et al. · 2014 [cited by applicant]
US 20140081113A1 · Cohen et al. · 2014 [cited by applicant]
US 20140088418A1 · Radulescu et al. · 2014 [cited by applicant]
US 20140171942A1 · Werneth et al. · 2014 [cited by applicant]
US 20150011843A1 · Toth et al. · 2015 [cited by applicant]
US 20150119708A1 · Sachse et al. · 2015 [cited by applicant]
US 20150182282A1 · Zemel et al. · 2015 [cited by applicant]
US 20150351722A1 · Chen et al. · 2015 [cited by applicant]
US 20160228180A1 · Sliwa et al. · 2016 [cited by applicant]
US 20170027503A1 · Sachse et al. · 2017 [cited by applicant]
US 20170061617A1 · Cochet et al. · 2017 [cited by applicant]
US 20170251963A1 · Hashimoto et al. · 2017 [cited by applicant]
US 20180103852A1 · Dagdeviren et al. · 2018 [cited by applicant]
US 20190223706A1 · Takeuchi et al. · 2019 [cited by applicant]
US 20200022573A1 · Sachse et al. · 2020 [cited by applicant]
US 20200246497A1 · Hara et al. · 2020 [cited by applicant]
CN 101453942A · 2009 [cited by applicant]
CN 103747756A · 2014 [cited by applicant]
CN 105163651A · 2015 [cited by applicant]
EP 2712546A1 · 2014 [cited by applicant]
JP 2004160212A · 2004 [cited by applicant]
JP 2005152654A · 2005 [cited by applicant]
JP 2008504557A · 2008 [cited by applicant]
JP 2009539566A · 2009 [cited by applicant]
JP 2012505028A · 2012 [cited by applicant]
JP 2012196437A · 2012 [cited by applicant]
JP 2016536065A · 2016 [cited by applicant]
JP 2017153876A · 2017 [cited by applicant]
JP 2019076621A · 2019 [cited by applicant]
JP 2019130155A · 2019 [cited by applicant]
JP 2019171021A · 2019 [cited by applicant]
WO 2006020920A2 · 2006 [cited by applicant]
WO 2007146864A3 · 2008 [cited by applicant]
WO 2014028584A1 · 2014 [cited by applicant]
WO 2014165990A1 · 2014 [cited by applicant]
WO 2015073932A1 · 2015 [cited by applicant]
WO 2015165978A1 · 2015 [cited by applicant]
WO 2016181318A1 · 2016 [cited by applicant]
WO 2016205731A1 · 2016 [cited by applicant]
WO 2018144648A1 · 2018 [cited by applicant]
Diaz et al., “Spectral classifier design with ensemble classifiers and misclassification-rejection: application to elastic-scattering spectroscopy for detection of colonic neoplasia”, Journal of biomedical optics., 16.6… [cited by applicant]
Femnou et al., “Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts”, JoVE (Journal of Visualized Experiments), 147 (2019):e5… [cited by applicant]
Final Office Action received for U.S. Appl. No. 15/222,858, mailed on Aug. 11, 2020, 13 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 16/482,389, mailed on Nov. 22, 2021, 18 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 15/222,858, mailed on Nov. 15, 2019. [cited by applicant]
International Search Report and Written Opinion for PCT/US2016/044845 mailed Oct. 7, 2016. [cited by applicant]
International Search Report and Written Opinion issued in PCT/US2018/016314 dated Mar. 12, 2018. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2020/065648, mailed on May 7, 2021, 12 pages. [cited by applicant]
Knighton et al., “Towards Cardiac Tissue Characterization Using Machine Learning and Light-Scattering Spectroscopy,” USA, 84112, 2015, 26 pages. [cited by applicant]
Knighton et al., “Towards Intraoperative Quantification of Atrial Fibrosis Using Light Scattering Spectroscopy and Convolutional Neural Networks,” UT 84112, USA, 16 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 15/222,858, mailed on Jan. 4, 2021, 13 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 16/482,389, mailed on Aug. 17, 2021, 21 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 16/482,389, mailed on May 5, 2022, 20 pages. [cited by applicant]
Office Action received for U.S. Appl. No. 15/222,858, mailed on Jan. 23, 2020. [cited by applicant]
Office Action received for U.S. Appl. No. 15/222,858, mailed on Feb. 28, 2019. [cited by applicant]
Rajitha et al., “Machine learning classification of human joint tissue from diffuse reflectance spectroscopy data”, Biomedical optics express, 10.8 (2019): 3889-3898. [cited by applicant]